Skip to main content
PEPG
NASDAQ Life Sciences

Favorable Safety, Splicing Trends Emerge for PepGen's Lead Drug PGN-EDODM1

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.18
Mkt Cap
$292.358M
52W Low
$0.88
52W High
$7.8
52W Position info
148% above low
Off High info
72% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

PEPG has more than doubled off its 52-week low of $0.88 on elevated volume (2.0× avg).

Summary

PepGen reported favorable safety and splicing trends from the 5 mg/kg cohort of its lead drug candidate, PGN-EDODM1, in the FREEDOM2 trial. The drug was generally well-tolerated with all adverse events being mild/moderate and no serious adverse events reported. Promising splicing correction was observed, with a mean of 22.9% for treated patients when an outlier was excluded. This positive data is a significant development for the company, especially following the partial clinical hold on its lead DM1 drug candidate and the discontinuation of its DMD program, as disclosed in its recent 10-K filing. The favorable results could help restore investor confidence and provide a clearer path forward for the program. Investors will now focus on the upcoming 10 mg/kg data readout expected in the second half of 2026, which represents the next major catalyst for the stock.

At the time of this announcement, PEPG was trading at $2.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $292.4M. The 52-week trading range was $0.88 to $7.80. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PEPG - Latest Insights

PEPG
Nov 11, 2026, 10:22 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $4.16 info
Change: -$1.19 (-22%) info
Market Cap: $290.205M info
PEPG
Nov 10, 2026, 4:23 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $4.89
Real-time Price: $4.16 info
Change: -$0.7244 (-15%) info
Market Cap: $290.205M info
PEPG
Nov 10, 2026, 7:05 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.40
Real-time Price: $4.16 info
Change: +$1.76 (+73%) info
Market Cap: $290.205M info
PEPG
Nov 10, 2026, 7:01 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $2.40
Real-time Price: $4.16 info
Change: +$1.76 (+73%) info
Market Cap: $290.205M info
PEPG
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.80
Real-time Price: $4.16 info
Change: +$1.36 (+49%) info
Market Cap: $290.205M info